MELODIE YOUNG: Open Payments
NPI 1356379218 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$167,036 in 420 payments from 28 companies in 2025. Trend: 2023 $201,185 · 2024 $174,438 · 2025 $167,036
Speaker / faculty: $80,291Consulting: $58,339Travel & lodging: $10,842Honoraria: $6,300Food & beverage: $5,794Speaker / faculty: $5,343
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 81 | $50,922 |
| Arcutis Biotherapeutics, Inc. | 61 | $28,702 |
| Janssen Biotech, Inc. | 28 | $20,126 |
| Eli Lilly and Company | 30 | $16,735 |
| UCB, Inc. | 38 | $16,116 |
| Organon LLC | 16 | $7,427 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 34 | $7,039 |
| Kowa Pharmaceuticals America, Inc. | 7 | $5,485 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $5,149 |
| LEO Pharma Inc. | 11 | $3,054 |
Products named: EBGLYSS, Zoryve, TREMFYA, Bimzelx, VTAMA, ILUMYA, TALTZ, OTEZLA.
Industry payments across TX — which companies pay providers there.
